Quadruple convergence – rising cannabis prevalence, intensity, concentration and use disorder treatment

Authors

Albert Stuart Reece, Edith Cowan UniversityFollow
Gary Kenneth Hulse, Edith Cowan UniversityFollow

Document Type

Other

Publication Title

The Lancet Regional Health - Europe

Volume

10

Publisher

Elsevier

School

School of Medical and Health Sciences

Comments

Reece, A. S., & Hulse, G. K. (2021). Quadruple convergence–rising cannabis prevalence, intensity, concentration and use disorder treatment. The Lancet Regional Health–Europe, 10, article 100245. https://doi.org/10.1016/j.lanepe.2021.100245

Abstract

In collating and synthesizing several data sources on cannabis exposure, Manthey and colleagues have elegantly compiled a foundational resource for subsequent epidemiological studies on cannabis use [1]. The study includes an impressive body of evidence on cannabis use prevalence (in the month and year prior to interview), high risk cannabis use (daily or near daily), tetrahydrocannabinol (THC—the principal psychoactive constituent of cannabis) concentration in European cannabis herb and processed resin (cannabis concentrates), and treatment demand for Cannabis Use Disorder (CUD). All four domains studied show a modest to dramatic increases across 2010-2019.

DOI

10.1016/j.lanepe.2021.100245

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.